|Title||Organization||LOI date||Due Date||Keywords||FOA|
|Collaborative Program Grant for Multidisciplinary Teams (RM1 - Clinical Trial Optional)||National Institutes of Health||Physician-Scientist, Environmental Contaminants, Immuno-oncology, Cancer Prevention, Limited||PAR-23-077|
|Elucidating Variability of Physiologic and Functional Responses to Exercise Training in Older Adults (R01 Clinical Trial Required)||National Institutes of Health||Myofascial Tissues, Global Health, Genomics, Behavior Change, Limited||RFA-AG-24-045|
|Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)||National Institutes of Health||animal models, Translational research, Limited||PAR-23-281|
|Margaret Q. Landenberger award||Margaret Q. Landenberger Research Foundation||10/10/2023||early-stage, therapuetic, intervention, limited|
|Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Data Coordinating Center (U24- Clinical Trial Not Allowed)||National Institutes of Health||10/27/2023||Early Career Investigator, Cancer Disparities, Gene Editing, Cancer Health Disparities, Limited||RFA-HL-24-007|
|Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Research Centers (U01 Clinical Trial Not Allowed)||National Institutes of Health||10/27/2023||Nanotechnology, Brain Disorders, Biomedical Systems, Biomarkers, Limited||RFA-HL-24-006|
|Cellular and Biochemical Engineering||National Science Foundation||12/31/2023||Health Equity Research, Cancer Disparities, Specifically named cancers (Various Cancer Types), Community Exposures, limited|
|Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)||National Institutes of Health||2/5/2024||Biomedical Imaging, In Vivo Imaging, Cancer Detection, Medical Technology, Limited||PAR-23-259|
|Advanced Research Projects Agency for Health (ARPA-H)||National Institutes of Health||3/14/2024||Biomedical Research, Health Technology, Disease Prevention, Biotechnology, Limited||75N99223S0001|
|2024 Blavatnik National Awards for Young Scientists||Blavatnik Family Foundation||9/25/2023||Limited, Early-stage, Chemistry, engineering|
For opportunities with Letter of Intent (LOI) due date listed, the LOI is required for full application submission. Please refer to RFA for details.
Can’t find what you’re looking for? Please contact Researchadmin@cancer.ufl.edu for assistance in finding additional funding opportunities.